tolazamide has been researched along with Diabetic Ketoacidosis in 2 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
Diabetic Ketoacidosis: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwee, IL | 1 |
| Nakada, T | 1 |
| Scoville, AB | 1 |
2 other studies available for tolazamide and Diabetic Ketoacidosis
| Article | Year |
|---|---|
Wernicke's encephalopathy induced by tolazamide.
Topics: Adult; Alcoholism; Diabetic Ketoacidosis; Humans; Male; Thiamine; Tolazamide; Wernicke Encephalopath | 1983 |
Editorial: Oral therapy in diabetes mellitus.
Topics: Acetohexamide; Biguanides; Chlorpropamide; Diabetes Mellitus; Diabetic Ketoacidosis; Diet Therapy; H | 1974 |